Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of a Circulating Tumor Cell-based Test (TriNetra™-Breast) for Breast Cancer Screening in Women Aged 40 and Above

NCT06043661 is registered in ClinicalTrials.gov with Datar Cancer Genetics Inc as lead sponsor.

NCT NCT06043661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06043661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of a Circulating Tumor Cell-based Test (TriNetra™-Breast) for Breast Cancer Screening in Women Aged 40 and Above
Lead sponsor
Datar Cancer Genetics Inc
Phase
Observational
Overall status
Unknown status
Start date
February 9, 2023
Completion date
December 31, 2025
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms